Aim Vascular endothelial growth factor (VEGF) is an angiogenic factor whose production is
increased in pre‐eclampsia (PE). Therefore, the present study was conducted aiming at …

Background Pre-eclampsia (PE) is a pregnancy complication and one of the leading causes
of maternal and neonatal morbidity and mortality in the world. PE is characterized by high …

Background: Preeclampsia remains as the leading cause of maternal-neonatal mortality and
morbidity worldwide. Vascular endothelial growth factor A (VEGF-A) is a proangiogenic …

Background Preeclampsia (PE) is the first worldwide cause of death in pregnant women,
intra-uterine growth retardation, and fetal prematurity. Some vascular endothelial grown …

ABSTRACT Background: Preeclampsia (PE), is a pregnancy-specific complication with the
placental origin which associated with altered expression of angiogenic factors. Vascular …

Several lines of evidence support the hypothesis that vascular endothelial growth factor
(VEGF) plays an important role in the pathogenesis of pre-eclampsia (PE). VEGF is a key …

OBJECTIVE: The purpose of this study was to evaluate potential associations between
vascular endothelial growth factor (VEGF) gene polymorphisms and preeclampsia. STUDY …

Vascular endothelial growth factor (VEGF) plays a crucial role in physiological
vasculogenesis and vascular permeability and has been implicated in the pathogenesis of …

Background Emerging evidence showed that VEGF gene polymorphisms are involved in the
regulation of VEGF protein expression, thus increasing an individual's susceptibility to …

Preeclampsia (PE) is a serious pregnancy-specific condition, which originates from placenta
and finishes after delivery. The present study has investigated the association between …